GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » EV-to-EBIT

YSB (HKSE:09885) EV-to-EBIT : 121.10 (As of May. 19, 2025)


View and export this data going back to 2023. Start your Free Trial

What is YSB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, YSB's Enterprise Value is HK$3,343 Mil. YSB's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was HK$28 Mil. Therefore, YSB's EV-to-EBIT for today is 121.10.

The historical rank and industry rank for YSB's EV-to-EBIT or its related term are showing as below:

HKSE:09885' s EV-to-EBIT Range Over the Past 10 Years
Min: -22.51   Med: -0.35   Max: 124.3
Current: 121.1

During the past 5 years, the highest EV-to-EBIT of YSB was 124.30. The lowest was -22.51. And the median was -0.35.

HKSE:09885's EV-to-EBIT is ranked worse than
94.64% of 448 companies
in the Healthcare Providers & Services industry
Industry Median: 16.965 vs HKSE:09885: 121.10

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. YSB's Enterprise Value for the quarter that ended in Dec. 2024 was HK$1,903 Mil. YSB's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was HK$28 Mil. YSB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 1.45%.


YSB EV-to-EBIT Historical Data

The historical data trend for YSB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YSB EV-to-EBIT Chart

YSB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBIT
- - - -0.99 69.33

YSB Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-EBIT Get a 7-Day Free Trial - - -0.99 - 69.33

Competitive Comparison of YSB's EV-to-EBIT

For the Pharmaceutical Retailers subindustry, YSB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YSB's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, YSB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where YSB's EV-to-EBIT falls into.


;
;

YSB EV-to-EBIT Calculation

YSB's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=3343.039/27.605
=121.10

YSB's current Enterprise Value is HK$3,343 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. YSB's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was HK$28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


YSB  (HKSE:09885) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

YSB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 ) =EBIT / Enterprise Value (Q: Dec. 2024 )
=27.605/1902.80332
=1.45 %

YSB's Enterprise Value for the quarter that ended in Dec. 2024 was HK$1,903 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. YSB's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was HK$28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


YSB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of YSB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


YSB Business Description

Traded in Other Exchanges
Address
No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.
Executives
Zhang Buzhen 2501 Other
Chen Xiaohong 2201 Interest of corporation controlled by you
H Capital V, L.p. 2101 Beneficial owner
H Capital V Gp, Ltd. 2201 Interest of corporation controlled by you
H Capital V Gp, L.p. 2201 Interest of corporation controlled by you
Shleifer Scott 2201 Interest of corporation controlled by you
Internet Fund Holding V. Ltd. 2201 Interest of corporation controlled by you
Tiger Global Management, Llc 2102 Investment manager
Tiger Global Pip Performance Xi, L.p. 2201 Interest of corporation controlled by you
Tiger Global Private Investment Partners Xi, L.p. 2101 Beneficial owner
Coleman Iii Charles 2201 Interest of corporation controlled by you
Miyt Worldwide Limited 2201 Interest of corporation controlled by you
Tmf (cayman) Ltd. 2301 Trustee
Internet Fund V Pte. Ltd. 2306 Nominee for another person
Miyt Holdings Limited 2101 Beneficial owner

YSB Headlines

No Headlines